The melanocyte stimulating hormone receptor polymorphism: Association of the V92M and A294H alleles with basal cell carcinoma

Clinica Chimica Acta

Volumn 282, Issue 1-2, 1999, Pages 125-134

  Jones, Fumiyo Ichii ^a   Ramachandran, Sudarshan ^a   Lear, John ^b   Smith, Andrew ^b   Bowers, Bill ^c   Ollier, William E R ^d   Jones, Peter ^a   Fryer, Anthony A ^a   Strange, Richard C ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b Ctrl Outpatients Dept N S   (United Kingdom)

^c ROYAL CORNWALL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

A294H; Allele; Basal cell carcinoma; Melanocyte stimulating hormone receptor; Susceptibility; V92M

Indexed keywords

HORMONE RECEPTOR; INTERMEDIN;

ADULT; ALLELE; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HAIR COLOR; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; FEMALE; HAIR COLOR; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, PITUITARY HORMONE; SKIN; SKIN NEOPLASMS;

EID: 0032901731     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00017-0     Document Type: Article

References (25)

1. Chuang T.Y., Popescu A., Su W.P.D. Basal cell carcinoma. A population based incidence study. J Am Acad Dermatol. 22:1990;413-417.
2. Miller D.L., Weinstock M.A. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol. 30:1994;774-778.
3. Kricker A., Armstrong B.K., Jones M.E., Burton R.C. Health, solar UV radiation and environmental change. 1993;52-61 International Agency for Research on Cancer, Lyon. Tech. Rep. no. 13.
4. Karagas M.R., Greenberg E.R. Unresolved issues in the epidemiology of basal cell and squamous cell skin cancer. Mukhtar H. Skin cancer: mechanisms and human relevance. 1995;79-86 CRC Press, Boca Raton, FL.
5. Rosso S., Zanetti R., Martinez C., Tormo M.J., Schraub S., Sanchogarnier H., et al. The multicentre south European study 'Helios'. II. Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer. 73:1996;1447-1454.
6. Kricker A., Armstrong B.K., English D.R., Heenan P.J. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer. 60:1995;482-488.
7. Karagas M.R., Stukel T.A., Greenberg R., Baron J.A., Mott L.A., Stern R.S. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. J Am Med Assoc. 267:1992;3305-3310.
8. Heagerty A.H.M., Fitzgerald D., Smith A., Bowers B., Jones P., Fryer A., et al. Glutathione S-transferase GSTM 1 phenotypes and protection against cutaneous malignancy. Lancet. 343:1994;266-268.
9. Kricker A., Armstrong B.K., English D.R. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 5:1994;367-392.
10. Lipton J.M., Catania A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today. 18:1997;140-145.
11. Valverde P., Healy E., Jackson I., Rees J.L., Thody A.J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 11:1995;328-330.
12. Suzuki I., Cone R.D., Sungbin I.M., Nordlund J., Abdel-Malek Z.A. Binding of melanotrophic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology. 137:1996;1627-1633.
13. Koppula S.V., Robbins L.S., Lu D.S., Baack E., White C.R., Swanson N.A., et al. Identification of common polymorphisms in the coding sequence of the human MSH receptor (MC1R) with possible biological effects. Hum Mutat. 9:1997;30-36.
14. Box N.F., Wyeth J.R., O'Gorman L.E., Martin N.G., Sturm R.A. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet. 6:1997;1891-1897.
15. Rees J.L., Healy E. Melanocortin receptors, red hair, and skin cancer. J Invest Dermatol Symp Proc. 2:1997;94-98.
16. Ichii-Jones F., Lear J.T., Heagerty A.H.M., Smith A.G., Hutchinson P.E., Osbourne J., et al. Susceptibility to malignant melanoma: Influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol. 111:1998;218-221.
17. Xu X., Thornwall M., Lundin L.-G., Chhajlani V. Val92met variant of the melanocyte stimulating hormone receptor gene. Nat Genet. 14:1996;384.
18. Lear J.T., Smith A.G., Bowers B., Heagerty A.H.M., Jones P.W., Gilford J., et al. Truncal tumour site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1Al genotypes, and their interaction. J Invest Dermatol. 108:1997;519-522.
19. Lear J.T., Heagerty A.H.M., Smith A., Bowers B., Payne C., Smith C.A.D., et al. Multiple cutaneous basal cell carcinomas: Glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1Al) polymorphisms influence tumour numbers and accrual. Carcinogenesis. 17:1996;1891-1896.
20. Fitzpatrick T.B. The validity and practicality of sun reaction skin types I through VI. Arch Dermatol. 124:1988;869-871.
21. Lear J.T., Tan B.B., Smith A.G., Bowers W., Jones P.W., Heagerty A.H., et al. Risk factors for basal cell carcinoma in the UK: Case-control study in 806 patients. J R Soc Med. 90:1997;371-374.
22. Lear J.T., Smith A.G., Heagerty A.H.M., Bower B., Jones P.W., Gilford J., et al. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma. Carcinogenesis. 18:1997;1499-1503.
23. Rosenberger W.F. Dealing with multiplicities in pharmacoepidemiologic studies. Pharmacoepidemiol Drug Saf. 5:1996;95-100.
24. Strange R.C., Lear I.T., Fryer A.A. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem-Biol Interact. 111-112:1998;351-364.
25. Fijnemann R.J.A., Jansen R.C., van der Valk M.A., Demant P. High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14. Cancer Res. 58:1998;4794-4798.